Medication Promises to Delay Bone Metastases in Men with Advanced Prostate Cancer

Share this content:


Denosumab may help prevent or delay time to bone metastases in men with non-metastatic castration-resistant prostate cancer.  This study is the first to demonstrate that targeting the bone microenvironment prevents bone metastasis in men with prostate cancer.

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters